PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

NCT06721689 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Refractory Solid Tumors
Relapsed Solid Tumors
Relapsed Neuroblastoma
Refractory Neuroblastoma
Relapsed Rhabdomyosarcoma
Refractory Rhabdomyosarcoma

Interventions

DRUG: PEEL-224
DRUG: Vincristine
DRUG: Temozolomide (TMZ)

Sponsor

Theodore Laetsch

Collaborators

[object Object]
[object Object]